Q32 Bio Inc
QTTB
NASDAQ
Biotechnology
$15.15
USD
-0.22 (-1.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $468.57M
Volume 311.8K
Price Target
$14.00 – $36.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $36.00 and a min estimate of $14.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$25.00
+$12.0 vs prior
Implied Upside
+65.0%
+79.2% vs prior
Analyst Covering
2
+1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
67%
Most ratings are recent - from the last 3 months
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Joseph Pantginis | HC Wainwright & Co. | Buy | Maintained | 2 weeks ago | Plus | Plus | Plus |
Joseph Catanzaro | Piper Sandler | Buy | Initiated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
CABA
Cabaletta Bio Inc
$2.75
▲ +1.5%
RZLT
Rezolute Inc
$4.60
▲ 0.0%
PRLD
Prelude Therapeutics Inc
$5.55
▲ +3.5%
EDIT
Editas Medicine Inc
$2.82
▲ +0.4%
KYTX
Kyverna Therapeutics Inc
$8.17
▲ +1.1%
LRMR
Larimar Therapeutics Inc
$4.36
▲ +2.1%
PBYI
Puma Biotechnology Inc
$8.83
▲ +1.4%
MPLT
MapLight Therapeutics Inc
$11.75
▲ +1.5%
OCGN
Ocugen Inc
$1.35
▲ 0.0%